RxDoctor Payments Data

Randall Demartino, MD

Vascular Surgery · Rochester, MNNPI 1982825204

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,285 of the $1,502 with a category attached, or 85.6%. 7 manufacturers reported payments, led by Boston Scientific at 30.2% of the total. That places this record below the midpoint for vascular surgery clinicians in MN, where the typical reported total is $3,317.

$1,502in general payments, 2019–2025

Across 21 payments — averaging $71.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$453
  • GE HealthCare$249
  • Cook Medical LLC$217
  • Philips North America LLC$205
  • Shape Memory Medical Inc.$165
  • Medtronic$139
  • plus $74 from 1 others
$214,124in research payments, 2019–2025

Across 61 payments — averaging $3510.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • W. L. Gore & Associates, Inc.$89K
  • Medtronic$73K
  • Shape Memory Medical Inc.$34K
  • Boston Scientific$14K
  • Cook Research Incorporated$4K

What the payments were for

  • Grants$21714%
  • Food & beverage$1,28586%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,502 in reported general payments places this provider in the 25th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$140,908
Medicare patients
227
Services billed
515

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban17$9,331
Doxycycline Monohydrate13$141
ClopidogrelClopidogrel Bisulfate11$85
Omeprazole13$67
Atorvastatin Calcium11$57

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →